EDGE Therapeutics

Business Summary

Founded in 2009, EDGE Therapeutics is a biotechnology company that raised an IPO in 2015, and was subsequently merged into PDS Biotechnology (NASDAQ: PDSB), a clinical stage biopharmaceutical company with a growing pipeline of cancer immunotherapies and infectious disease vaccines.

The H/L Ventures Thesis
Protecting Promoting
People Health & Wellness, Safe Medication
Planet

Sustainable Development Goals

  • Good Health and Well-Being

Sector

  • Biotechnology

Stage

  • Exited

Vehicles

  • H/L Studio
Back to top